BAG4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.310400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.200000E-01
Normal-vs-Stage2
9.718600E-01
Normal-vs-Stage3
1.219750E-01
Normal-vs-Stage4
3.241400E-01
Stage1-vs-Stage2
5.152200E-01
Stage1-vs-Stage3
3.308400E-01
Stage1-vs-Stage4
1.031750E-01
Stage2-vs-Stage3
1.983730E-03
Stage2-vs-Stage4
2.102800E-01
Stage3-vs-Stage4
6.424400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.932600E-01
Normal-vs-AfricanAmerican
8.142000E-01
Normal-vs-Asian
7.621200E-01
Caucasian-vs-AfricanAmerican
5.082600E-01
Caucasian-vs-Asian
6.727800E-01
AfricanAmerican-vs-Asian
5.013600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.733600E-01
Normal-vs-Female
8.678400E-01
Male-vs-Female
6.688200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.804800E-01
Normal-vs-Age(41-60Yrs)
8.652800E-01
Normal-vs-Age(61-80Yrs)
8.214200E-01
Normal-vs-Age(81-100Yrs)
9.594600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.287800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.942600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.046200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.613600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.197800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.138000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.683600E-01
Normal-vs-Daily Drinker
7.875200E-01
Normal-vs-Weekly Drinker
9.446800E-01
Normal-vs-Occasional Drinker
8.813600E-01
Normal-vs-Social Drinker
8.536600E-01
Non Drinker-vs-Daily Drinker
8.854800E-01
Non Drinker-vs-Weekly Drinker
4.616600E-01
Non Drinker-vs-Occasional Drinker
2.470200E-01
Non Drinker-vs-Social Drinker
1.811250E-01
Daily Drinker-vs-Weekly Drinker
6.972400E-01
Daily Drinker-vs-Occasional Drinker
4.267000E-01
Daily Drinker-vs-Social Drinker
4.175600E-01
Weekly Drinker-vs-Occasional Drinker
7.083400E-01
Weekly Drinker-vs-Social Drinker
6.748200E-01
Occasional Drinker-vs-Social Drinker
9.528400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.836850E-01
Normal-vs-Grade 2
4.644000E-02
Normal-vs-Grade 3
4.906300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.562200E-03
Grade 1-vs-Grade 3
1.201810E-03
Grade 1-vs-Grade 4
1.836850E-01
Grade 2-vs-Grade 3
8.755800E-02
Grade 2-vs-Grade 4
4.644000E-02
Grade 3-vs-Grade 4
4.906300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.990000E-01
Normal-vs-NonDiabetic
8.586800E-01
Diabetic-vs-NonDiabetic
7.678800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.453800E-01
Normal-vs-NoPancreatitis
9.234400E-01
Pancreatitis-vs-NoPancreatitis
1.202810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.036800E-01
Normal-vs-N1
9.449200E-01
N0-vs-N1
1.246380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.930000E-01
Normal-vs-TP53-NonMutant
7.455200E-01
TP53-Mutant-vs-TP53-NonMutant
1.742330E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
